Jay Moyes

Track

Insider profile

Currently holds positions in BioCardia Inc and Puma Biotechnology Inc

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 15% 8.2% 15.1%
Success rate 81% 68% 82%
Transactions
5 40% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director BioCardia Inc Jan. 1, 2011 -
Lead Independent Director Puma Biotechnology Inc Jan. 1, 2018 -
Independent Director Predictive Technology Group Inc Feb. 28, 2019 - Jan. 1, 2020
Independent Director Puma Biotechnology Inc April 27, 2012 - Jan. 1, 2018
Independent Director Osiris Therapeutics Inc Aug. 14, 2006 - Dec. 13, 2017
Chief Financial Officer, Director SINTX Technologies Inc Oct. 1, 2013 - Aug. 8, 2014
Chief Financial Officer CareDx, Inc. May 20, 2008 - March 1, 2014
Director SINTX Technologies Inc Nov. 1, 2012 - Oct. 1, 2013
Jay Moyes's trades of Puma Biotechnology Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
378.71
Quantity 15,667 -34.8%
Value US$4,461,327
Transaction date
Proposed sale
Price
445.00
Quantity 22,307
Value US$1,585,404
Transaction date
Purchase
Price
128.91
Quantity 64,804 -8.8%
Value US$1,684,332
Transaction date
Purchase
Price
3.59
Quantity 3,000 +inf%
Value US$10,756
Transaction date
Proposed sale
Price
3.40
Quantity 22,000
Value US$74,756
Transaction date
Proposed sale
Price
3.60
Quantity 22,000
Value US$79,090
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-15 2026-06-12
PlS Planned sale
15,667 -34.8%
378.71
US$4,461,327 		15,667 -34.8% 378.71 US$4,461,327
2026-06-12 2026-06-12
PrS Proposed sale
22,307
445.00
US$1,585,404 		22,307 445.00 US$1,585,404
2026-02-25 2026-02-23
B Purchase
64,804 -8.8%
128.91
US$1,684,332 		64,804 -8.8% 128.91 US$1,684,332
2025-08-27 2025-08-26
B Purchase
3,000 +inf%
3.59
US$10,756 		3,000 +inf% 3.59 US$10,756
2025-06-17 2025-06-13
PlS Planned sale
22,000 -29.2%
3.40
US$74,800 		22,000 -29.2% 3.40 US$74,800
2025-06-13 2025-06-13
PrS Proposed sale
22,000
3.40
US$74,756 		22,000 3.40 US$74,756
2024-06-17 2024-06-13
PlS Planned sale
22,000 -50.8%
3.34
US$73,467 		22,000 -50.8% 3.34 US$73,467
2024-06-13 2024-06-13
PrS Proposed sale
22,000
3.60
US$79,090 		22,000 3.60 US$79,090
2023-06-15 2023-06-13
PlS Planned sale
22,000 -57.4%
3.45
US$75,970 		22,000 -57.4% 3.45 US$75,970
2023-06-13 2023-06-13
PrS Proposed sale
22,000
3.46
US$76,120 		22,000 3.46 US$76,120
2022-06-21 2022-06-16
PlS Planned sale
22,858 -37.4%
2.64
US$60,370 		22,858 -37.4% 2.64 US$60,370
2021-06-11 2021-06-10
S Sale
25,248 -80.0%
11.36
US$286,860 		25,248 -80.0% 11.36 US$286,860
2020-09-17 2020-09-16
S Sale
9,703 -23.5%
10.00
US$97,030 		9,703 -23.5% 10.00 US$97,030
2020-06-17 2020-06-16
S Sale
9,720 -19.1%
9.50
US$92,340 		9,720 -19.1% 9.50 US$92,340